Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...
Nvidia (NVDA) saw its stock drop more than 13% on Monday, wiping nearly $480 billion from its market cap. This sharp decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback